Akèy › Kansè vejik › Minnesota

Etid klinik pou Kansè vejik nan Minnesota

24 etid pou Kansè vejik ap chèche patisipan nan sit nan Minnesota.

Vil nan Minnesota

Tèks ofisyèl etid la (Anglè)

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Sanford Joe Lueken Cancer Center, Bemidji
Fairview Southdale Hospital, Edina
Abbott-Northwestern Hospital, Minneapolis
ak 1 plis

Ap rekriteFaz 2

Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07061964

Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial

Mayo Clinic in Rochester, Rochester

Ap rekriteFaz 4

Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06764095

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Health Partners Frauenshuh Cancer Center, Saint Louis Park
Health Partners Cancer Center at Regions Hospital, Saint Paul

Ap rekriteFaz 2

Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06172478

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Essentia Health - Deer River Clinic, Deer River
Essentia Health Cancer Center, Duluth
Fairview Southdale Hospital, Edina
ak 8 plis

Ap rekriteFaz 2

Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Essentia Health Saint Joseph's Medical Center, Brainerd
Essentia Health - Deer River Clinic, Deer River
Essentia Health Cancer Center, Duluth
ak 5 plis

Ap rekriteFaz 2

Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT06770582

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Mayo Clinic Rochester, Rochester

Ap rekriteFaz 1

Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07277413

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Minnesota Oncology and Hematology PA, Minneapolis

Ap rekriteFaz 1/2

Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT05267626

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Mayo Clinic (Rochester), Rochester

Ap rekriteEtid obsèvasyon

Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT05059444

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

Mayo Clinic Rochester, Rochester
Minnesota Urology, Woodbury

Ap rekriteFaz 2

Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT06567743

The Vanguard Study: Testing a New Way to Screen for Cancer

Minneapolis VA Medical Center, Minneapolis

Ap rekriteVolontè an sante akeyi

Laj 45 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT06995898

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Riverwood Healthcare Center, Aitkin
Mayo Clinic Health System in Albert Lea, Albert Lea
Essentia Health - Baxter Clinic, Baxter
ak 48 plis

Ap rekriteEtid obsèvasyonVolontè an sante akeyi

Laj 40 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT05334069

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

Minnesota Urology, Woodbury, Bloomington
Mayo Clinic, Rochester

Ap rekriteFaz 2

Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT05951179

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Minnesota Oncology - Burnsville, Burnsville
Mercy Hospital, Coon Rapids
Fairview Southdale Hospital, Edina
ak 16 plis

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07097142

Exploration of HRQOL and Urinary Outcomes Following Partial Cystectomy

Mayo Clinic in Rochester, Rochester

Ap rekriteEtid obsèvasyon

Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT06891209

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

University of Minnesota, Minneapolis
Mayo Clinic, Rochester

Ap rekriteFaz 1/2

Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT04752722

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

Mayo Clinic in Rochester, Rochester

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT07000084

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

St. Luke's Hospital, Duluth

Ap rekriteFaz 2

Laj 8 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT05503797

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Allina Health Cancer Institute - Mercy Hospital, Coon Rapids
Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis
Allina Health Cancer Institute - United Hospital, Saint Paul
ak 1 plis

Ap rekriteFaz 1

Laj 18 ak plis · Tout sèks · Mizajou Jul 6, 2026 · NCT04389632

Integrated Cancer Repository for Cancer Research

Riverwood Healthcare Center, Aitkin
Essentia Health-St. Joseph's Medical Center, Brainerd
Essentia Health - Duluth Clinic, Duluth
ak 2 plis

Ap rekriteEtid obsèvasyonVolontè an sante akeyi

Laj 19 a 110 · Tout sèks · Mizajou Jun 29, 2026 · NCT02012699

Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers

Mayo Clinic in Rochester, Rochester

Ap rekriteFaz 2

Laj 18 ak plis · Tout sèks · Mizajou May 8, 2026 · NCT07087860

Bladder Bank (a Prospective Banking Study)

Mayo Clinic in Rochester, Rochester

Ap rekriteEtid obsèvasyon

Laj 18 ak plis · Tout sèks · Mizajou Mar 16, 2026 · NCT06109857

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Allina Health Cancer Institute, Minneapolis
Mayo Clinic, Rochester

Ap rekriteEtid obsèvasyonVolontè an sante akeyi

Laj 40 ak plis · Tout sèks · Mizajou Jan 20, 2026 · NCT05366881

Blue Light Cystoscopy With Cysview® Registry

University of Minnesota, Minneapolis

Ap rekriteEtid obsèvasyon

Laj 18 ak plis · Tout sèks · Mizajou Dec 18, 2025 · NCT02660645

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Duluth

Ap rekriteEtid obsèvasyon

Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.